Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis

Journal of Clinical Oncology, 04/25/2012

This analysis supports adjuvant therapy (AT) for biliary tract cancer (BTC). Prospective randomized trials are needed to provide better rationale for this commonly used strategy. On the basis of the data, such trials could involve two active comparators rather than a no–treatment arm among patients with lymph node (LN)–positive or R1 disease.

Print Article Summary Cat 2 CME Report